Clinical Applications of Plasma Epstein-Barr Virus DNA Analysis and Protocols for the Quantitative Analysis of the Size of Circu
Nasopharyngeal carcinoma (NPC) is one of the most common cancers in Southern China. Epstein-Barr virus (EBV) infection is an important etiological factor of NPC. The fact that EBV genome is present in almost all NPC tissues renders it an ideal tumor marker for NPC. To date, quantitative analysis of plasma EBV DNA has been shown to be clinically useful for the detection, monitoring, and prognostication of NPC. In addition, the molecular nature of circulating EBV DNA has recently been identified as that of free DNA fragments; it is not contained inside intact virions. By quantitative size analysis, it is further demonstrated that more than 80% of these DNA fragments are less than 180 bp in size. In this chapter, the clinical applications of plasma EBV DNA analysis and the protocols for the quantitative analysis of the size of circulating EBV DNA will be discussed.
- The Use of Molecular Beacons to Detect and Quantify MicroRNA
- Isolation and Mass Spectrometry of Specific DNProteins
- Detection of Chlamydia trachomatis by DNA Amplification
- Gene Targeting for Somatic Cell Manipulation
- Identification of Molecular Markers to Follow Up the Bioremediation of Sites Contaminated with Chlorinated Compounds
- Expression Profiling of Components of the miRNA Maturation Machinery
- Expression Monitoring Using cDNA Microarrays: A General Protocol
- The Pathway of miRNA Maturation
- The Use of Robotic Workstations in DNA Sequencing
- Monitoring the Topoisomerase II DNA Gate Conformational Change with Fluorescence Resonance Energy Transfer